IDALLO study: A retrospective multicenter study of the SFGM-TC evaluating the efficacy and safety of ivosidenib in relapsed IDH1-mutated AML after allogeneic hematopoietic cell transplantation.

ABSTRACT:

SUBMITTER: Caillet A 

PROVIDER: S-EPMC10925725 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature